The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

News about ISCIII

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

Subscribe to the Newsletter of Clínic